Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during the lipopolysaccharide-mediated acute-phase response

M. R. An, C. C. Hsieh, P. D. Reisner, J. P. Rabek, S. G. Scott, D. T. Kuninger, John Papaconstantinou

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

The mRNAs of the CCAAT/enhancer-binding trans-activator proteins (C/EBPα and C/EBPβ) serve as templates for the differential translation of several isoforms which have specific transcriptional regulatory functions. By using an oligonucleotide corresponding to the C/EBP binding site of the mouse α1- acid glycoprotein promoter, we detected multiple forms of C/EBPα and C/EBPβ proteins in the mouse liver that have DNA-binding activity. By using specific antisera, we detected C/EBPαs with molecular masses of 42, 38, 30, and 20 kDa that have DNA-binding activity. The pool levels of the 42- and 30-kDa isoforms were high in control nuclear extracts and decreased significantly after lipopolysaccharide (LPS) treatment. The binding activity and protein levels of the 20-kDa isoform are low in controls and increase dramatically after LPS treatment. C/EBPβ isoforms with molecular masses of 35, 20, and 16 kDa were also detected. The 35-kDa pool level did not change whereas the 20- kDa isoform was strongly induced in response to LPS. Western (immunoblot) and Southwestern (DNA-protein) analyses show that p42(C/EBPα) forms specific complexes with the α1-acid glycoprotein oligonucleotide in control nuclear extract and that p20(C/EBPβ) forms complexes in LPS-treated liver. Our studies suggest that synthesis of specific C/EBpα and C/EBPβ isoforms occurred in the normal liver in vivo and that LPS mediated a differential initiation and inhibition of translation at specific AUG sites within each mRNA. The qualitative and quantitative changes in C/EBPα and C/EBPβ isoform pool levels suggest that LPS or an LPS-stimulated factor can regulate the selection of AUG start sites for both activation and repression of translation. This regulation appears to involve an LPS-mediated down- regulation of initiation at the first AUG codon of the 42-kDa C/EBPα and dramatic translational up-regulation at the fifth AUG codon of the 20-kDa C/EBPα and the third AUG codon of the 20-kDa C/EBPβ. These regulatory events suggest the existence of proteins that may act as translational trans- acting factors.

Original languageEnglish (US)
Pages (from-to)2295-2306
Number of pages12
JournalMolecular and Cellular Biology
Volume16
Issue number5
StatePublished - May 1996

Fingerprint

Acute-Phase Reaction
Lipopolysaccharides
Protein Isoforms
Codon
CCAAT-Enhancer-Binding Proteins
Trans-Activators
Oligonucleotides
Liver
DNA
Glycoproteins
Messenger RNA
Acids
Immune Sera
Carrier Proteins
Proteins
Up-Regulation
Down-Regulation
Western Blotting
Binding Sites

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during the lipopolysaccharide-mediated acute-phase response. / An, M. R.; Hsieh, C. C.; Reisner, P. D.; Rabek, J. P.; Scott, S. G.; Kuninger, D. T.; Papaconstantinou, John.

In: Molecular and Cellular Biology, Vol. 16, No. 5, 05.1996, p. 2295-2306.

Research output: Contribution to journalArticle

An, M. R. ; Hsieh, C. C. ; Reisner, P. D. ; Rabek, J. P. ; Scott, S. G. ; Kuninger, D. T. ; Papaconstantinou, John. / Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during the lipopolysaccharide-mediated acute-phase response. In: Molecular and Cellular Biology. 1996 ; Vol. 16, No. 5. pp. 2295-2306.
@article{7fb7ae23d5e84a88b05eb59f1394682d,
title = "Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during the lipopolysaccharide-mediated acute-phase response",
abstract = "The mRNAs of the CCAAT/enhancer-binding trans-activator proteins (C/EBPα and C/EBPβ) serve as templates for the differential translation of several isoforms which have specific transcriptional regulatory functions. By using an oligonucleotide corresponding to the C/EBP binding site of the mouse α1- acid glycoprotein promoter, we detected multiple forms of C/EBPα and C/EBPβ proteins in the mouse liver that have DNA-binding activity. By using specific antisera, we detected C/EBPαs with molecular masses of 42, 38, 30, and 20 kDa that have DNA-binding activity. The pool levels of the 42- and 30-kDa isoforms were high in control nuclear extracts and decreased significantly after lipopolysaccharide (LPS) treatment. The binding activity and protein levels of the 20-kDa isoform are low in controls and increase dramatically after LPS treatment. C/EBPβ isoforms with molecular masses of 35, 20, and 16 kDa were also detected. The 35-kDa pool level did not change whereas the 20- kDa isoform was strongly induced in response to LPS. Western (immunoblot) and Southwestern (DNA-protein) analyses show that p42(C/EBPα) forms specific complexes with the α1-acid glycoprotein oligonucleotide in control nuclear extract and that p20(C/EBPβ) forms complexes in LPS-treated liver. Our studies suggest that synthesis of specific C/EBpα and C/EBPβ isoforms occurred in the normal liver in vivo and that LPS mediated a differential initiation and inhibition of translation at specific AUG sites within each mRNA. The qualitative and quantitative changes in C/EBPα and C/EBPβ isoform pool levels suggest that LPS or an LPS-stimulated factor can regulate the selection of AUG start sites for both activation and repression of translation. This regulation appears to involve an LPS-mediated down- regulation of initiation at the first AUG codon of the 42-kDa C/EBPα and dramatic translational up-regulation at the fifth AUG codon of the 20-kDa C/EBPα and the third AUG codon of the 20-kDa C/EBPβ. These regulatory events suggest the existence of proteins that may act as translational trans- acting factors.",
author = "An, {M. R.} and Hsieh, {C. C.} and Reisner, {P. D.} and Rabek, {J. P.} and Scott, {S. G.} and Kuninger, {D. T.} and John Papaconstantinou",
year = "1996",
month = "5",
language = "English (US)",
volume = "16",
pages = "2295--2306",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during the lipopolysaccharide-mediated acute-phase response

AU - An, M. R.

AU - Hsieh, C. C.

AU - Reisner, P. D.

AU - Rabek, J. P.

AU - Scott, S. G.

AU - Kuninger, D. T.

AU - Papaconstantinou, John

PY - 1996/5

Y1 - 1996/5

N2 - The mRNAs of the CCAAT/enhancer-binding trans-activator proteins (C/EBPα and C/EBPβ) serve as templates for the differential translation of several isoforms which have specific transcriptional regulatory functions. By using an oligonucleotide corresponding to the C/EBP binding site of the mouse α1- acid glycoprotein promoter, we detected multiple forms of C/EBPα and C/EBPβ proteins in the mouse liver that have DNA-binding activity. By using specific antisera, we detected C/EBPαs with molecular masses of 42, 38, 30, and 20 kDa that have DNA-binding activity. The pool levels of the 42- and 30-kDa isoforms were high in control nuclear extracts and decreased significantly after lipopolysaccharide (LPS) treatment. The binding activity and protein levels of the 20-kDa isoform are low in controls and increase dramatically after LPS treatment. C/EBPβ isoforms with molecular masses of 35, 20, and 16 kDa were also detected. The 35-kDa pool level did not change whereas the 20- kDa isoform was strongly induced in response to LPS. Western (immunoblot) and Southwestern (DNA-protein) analyses show that p42(C/EBPα) forms specific complexes with the α1-acid glycoprotein oligonucleotide in control nuclear extract and that p20(C/EBPβ) forms complexes in LPS-treated liver. Our studies suggest that synthesis of specific C/EBpα and C/EBPβ isoforms occurred in the normal liver in vivo and that LPS mediated a differential initiation and inhibition of translation at specific AUG sites within each mRNA. The qualitative and quantitative changes in C/EBPα and C/EBPβ isoform pool levels suggest that LPS or an LPS-stimulated factor can regulate the selection of AUG start sites for both activation and repression of translation. This regulation appears to involve an LPS-mediated down- regulation of initiation at the first AUG codon of the 42-kDa C/EBPα and dramatic translational up-regulation at the fifth AUG codon of the 20-kDa C/EBPα and the third AUG codon of the 20-kDa C/EBPβ. These regulatory events suggest the existence of proteins that may act as translational trans- acting factors.

AB - The mRNAs of the CCAAT/enhancer-binding trans-activator proteins (C/EBPα and C/EBPβ) serve as templates for the differential translation of several isoforms which have specific transcriptional regulatory functions. By using an oligonucleotide corresponding to the C/EBP binding site of the mouse α1- acid glycoprotein promoter, we detected multiple forms of C/EBPα and C/EBPβ proteins in the mouse liver that have DNA-binding activity. By using specific antisera, we detected C/EBPαs with molecular masses of 42, 38, 30, and 20 kDa that have DNA-binding activity. The pool levels of the 42- and 30-kDa isoforms were high in control nuclear extracts and decreased significantly after lipopolysaccharide (LPS) treatment. The binding activity and protein levels of the 20-kDa isoform are low in controls and increase dramatically after LPS treatment. C/EBPβ isoforms with molecular masses of 35, 20, and 16 kDa were also detected. The 35-kDa pool level did not change whereas the 20- kDa isoform was strongly induced in response to LPS. Western (immunoblot) and Southwestern (DNA-protein) analyses show that p42(C/EBPα) forms specific complexes with the α1-acid glycoprotein oligonucleotide in control nuclear extract and that p20(C/EBPβ) forms complexes in LPS-treated liver. Our studies suggest that synthesis of specific C/EBpα and C/EBPβ isoforms occurred in the normal liver in vivo and that LPS mediated a differential initiation and inhibition of translation at specific AUG sites within each mRNA. The qualitative and quantitative changes in C/EBPα and C/EBPβ isoform pool levels suggest that LPS or an LPS-stimulated factor can regulate the selection of AUG start sites for both activation and repression of translation. This regulation appears to involve an LPS-mediated down- regulation of initiation at the first AUG codon of the 42-kDa C/EBPα and dramatic translational up-regulation at the fifth AUG codon of the 20-kDa C/EBPα and the third AUG codon of the 20-kDa C/EBPβ. These regulatory events suggest the existence of proteins that may act as translational trans- acting factors.

UR - http://www.scopus.com/inward/record.url?scp=0029920849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029920849&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 2295

EP - 2306

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 5

ER -